Table 1

Number of SARS-Cov-2 infections, ICU admissions and death in the general population compared to DMARD treated patients as well as calculated incidences

General populationDMARD-treated patients with rheumatic diseases
Total, n1.814.00010.771
SARS-CoV-2 infected, n (%)5120 (0.28)30 (0.25)
ICU, n (%)227 (4.4)3 (10)
Death, n (%)226 (4.4)0 (0)
  • DMARD, disease-modifying antirheumatic drug; ICU, intensive care unit; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.